The James Hutton Institute

United Kingdom

Back to Profile

1-30 of 30 for The James Hutton Institute Sort by
Query
Aggregations
IP Type
        Patent 23
        Trademark 7
Jurisdiction
        World 9
        United States 9
        Canada 8
        Europe 4
Date
2024 4
2023 2
2022 6
2020 2
Before 2020 16
IPC Class
A61K 39/00 - Medicinal preparations containing antigens or antibodies 7
A61P 37/04 - Immunostimulants 6
C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof 5
A61K 39/12 - Viral antigens 4
A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus 4
See more
NICE Class
31 - Agricultural products; live animals 4
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 3
41 - Education, entertainment, sporting and cultural services 2
42 - Scientific, technological and industrial services, research and design 2
29 - Meat, dairy products, prepared or preserved foods 1
See more
Status
Pending 11
Registered / In Force 19

1.

BIODEGRADABLE AND REUSABLE CELLULOSIC MICROPOROUS SUPERABSORBENT MATERIALS

      
Application Number 18580652
Status Pending
Filing Date 2022-07-20
First Publication Date 2024-08-22
Owner
  • CELLUCOMP LIMITED (United Kingdom)
  • THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Whale, Eric Arron
  • Hepworth, David Gwyddon
  • Love, Andrew John
  • Squires, Julie Nicola

Abstract

The present invention relates to a process for preparing an antimicrobial cellulose-containing microporous superabsorbent composition from an herbaceous plant material, the process comprising the step of comminuting dry granulated herbaceous plant material to form microparticles having an average particle diameter of from 100 μm to 800 μm; to obtain the cellulose-containing microporous superabsorbent composition.

IPC Classes  ?

  • A61L 15/60 - Liquid-swellable gel-forming materials, e.g. super-absorbents
  • A61L 15/42 - Use of materials characterised by their function or physical properties
  • C08L 97/02 - Lignocellulosic material, e.g. wood, straw or bagasse

2.

FLEXIBLE EXPRESSION VECTOR SYSTEMS AND APPLICATION OF SAME TO VACCINES AND IMMUNOTHERAPEUTICS

      
Application Number 18564149
Status Pending
Filing Date 2022-05-26
First Publication Date 2024-08-01
Owner
  • The University Of British Columbia (Canada)
  • The James Hutton Institute (United Kingdom)
Inventor
  • Jefferies, Wilfred A.
  • Ribeca, Paolo

Abstract

The present invention relates to an expression vector that encodes all or a portion of replicon proteins from a positive stranded virus, wherein expression of the replicon proteins is under the control of CMV and T7 promoters, and wherein expression of a payload is under the control of a sub-genomic promoter. Also provided are methods of using the vector in therapeutics and vaccines.

IPC Classes  ?

  • C12N 15/86 - Viral vectors
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/20 - Rubella virus
  • A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
  • A61P 31/14 - Antivirals for RNA viruses
  • A61P 37/04 - Immunostimulants

3.

SARS-COV-2 MULTI-EPITOPE VACCINES

      
Application Number 18558241
Status Pending
Filing Date 2022-05-05
First Publication Date 2024-07-18
Owner
  • THE UNIVERSITY OF BRITISH COLUMBIA (Canada)
  • THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Jefferies, Wilfred
  • Ribeca, Paolo

Abstract

The present invention provides multi-epitope vaccines comprising or capable of expressing one or more concatemers of epitopes from a viral pathogen, namely, SARS-COV-2. wherein at least a portion of the epitopes are from conserved viral proteins and wherein the vaccine comprises or expresses epitopes for all MHC I and MHC II alleles with a frequency >1% in the target population.

IPC Classes  ?

  • A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • C12N 15/86 - Viral vectors

4.

BINARY SELF-AMPLIFYING NUCLEIC ACID PLATFORM AND USES THEREOF

      
Application Number CA2023051444
Publication Number 2024/092346
Status In Force
Filing Date 2023-10-31
Publication Date 2024-05-10
Owner
  • THE UNIVERSITY OF BRITISH COLUMBIA (Canada)
  • THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Jefferies, Wilfred Arthur
  • Choi, Kyung-Bok
  • Ribeca, Paolo

Abstract

The present invention relates to an expression vector that encodes all or a portion of replicon proteins from a positive stranded virus, wherein expression of the replicon proteins is under the control of CMV and T7 promoters, and wherein expression of a payload is under the control of a sub-genomic promoter. Also provided are methods of using the vector in therapeutics and vaccines.

IPC Classes  ?

  • C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61P 37/04 - Immunostimulants
  • C07K 14/18 - Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus
  • C12N 15/40 - Proteins from RNA viruses, e.g. flaviviruses
  • C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression

5.

A METHOD OF EPITOPE-BASED VACCINE DESIGN

      
Application Number 18036375
Status Pending
Filing Date 2021-11-23
First Publication Date 2023-12-14
Owner
  • The University of British Columbia (Canada)
  • The James Hutton Institute (United Kingdom)
Inventor
  • Jefferies, Wilfred
  • Ribeca, Paolo

Abstract

The present invention provides a method of epitope-based vaccine design. The method comprising: a) providing one or more target amino acid sequence(s); b) optionally discarding peptides based on one or more predetermined features; c) parsing and selecting MHC I and/or MHC II binding peptides from said sequences; and d) assembling the MHC I and/or MHC II binding peptides optionally with linkers to produce an assembly of peptides.

IPC Classes  ?

  • G16B 35/20 - Screening of libraries
  • G16B 20/40 - Population geneticsLinkage disequilibrium
  • G16B 40/00 - ICT specially adapted for biostatisticsICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

6.

BIODEGRADABLE AND REUSABLE CELLULOSIC MICROPOROUS SUPERABSORBENT MATERIALS

      
Application Number EP2022070401
Publication Number 2023/001911
Status In Force
Filing Date 2022-07-20
Publication Date 2023-01-26
Owner
  • CELLUCOMP LIMITED (United Kingdom)
  • THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Whale, Eric Arron
  • Hepworth, David Gwyddon
  • Love, Andrew John
  • Squires, Julie Nicola

Abstract

The present invention relates to a process for preparing an antimicrobial cellulose-containing microporous superabsorbent composition from an herbaceous plant material, the process comprising the step of comminuting dry granulated herbaceous plant material to form microparticles having an average particle diameter of from 100 μm to 800 μm; to obtain the cellulose -containing microporous superabsorbent composition.

IPC Classes  ?

  • A01N 25/10 - Macromolecular compounds
  • A01N 25/34 - Shaped forms, e.g. sheets, not provided for in any other group of this main group
  • A01N 59/16 - Heavy metalsCompounds thereof
  • A01N 65/00 - Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
  • A01N 65/08 - Magnoliopsida [dicotyledons]
  • A01P 1/00 - DisinfectantsAntimicrobial compounds or mixtures thereof
  • A61F 13/00 - Bandages or dressingsAbsorbent pads
  • A61L 15/28 - Polysaccharides or their derivatives
  • B01D 46/00 - Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
  • A01N 25/24 - Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of applicationSubstances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients to enhance the sticking of the active ingredients
  • C08L 5/06 - PectinDerivatives thereof
  • C08L 97/02 - Lignocellulosic material, e.g. wood, straw or bagasse
  • C08L 99/00 - Compositions of natural macromolecular compounds or of derivatives thereof not provided for in groups or

7.

FLEXIBLE EXPRESSION VECTOR SYSTEMS AND APPLICATION OF SAME TO VACCINES AND IMMUNOTHERAPEUTICS

      
Document Number 03218783
Status Pending
Filing Date 2022-05-26
Open to Public Date 2022-12-01
Owner
  • UNIVERSITY OF BRITISH COLUMBIA (Canada)
  • THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Ribeca, Paolo
  • Jefferies, Wilfred A.

Abstract

The present invention relates to an expression vector that encodes all or a portion of replicon proteins from a positive stranded virus, wherein expression of the replicon proteins is under the control of CMV and T7 promoters, and wherein expression of a payload is under the control of a sub-genomic promoter. Also provided are methods of using the vector in therapeutics and vaccines.

IPC Classes  ?

  • A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
  • A61K 31/713 - Double-stranded nucleic acids or oligonucleotides
  • A61K 39/12 - Viral antigens
  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
  • A61K 49/00 - Preparations for testing in vivo
  • A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P 31/12 - Antivirals
  • A61P 37/04 - Immunostimulants
  • C07K 14/08 - RNA viruses
  • C07K 14/165 - Coronaviridae, e.g. avian infectious bronchitis virus
  • C07K 14/18 - Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus
  • C07K 14/19 - Rubella virus
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/40 - Proteins from RNA viruses, e.g. flaviviruses
  • C12N 15/50 - Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus
  • C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
  • C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells

8.

FLEXIBLE EXPRESSION VECTOR SYSTEMS AND APPLICATION OF SAME TO VACCINES AND IMMUNOTHERAPEUTICS

      
Application Number CA2022050841
Publication Number 2022/246559
Status In Force
Filing Date 2022-05-26
Publication Date 2022-12-01
Owner
  • THE UNIVERSITY OF BRITISH COLUMBIA (Canada)
  • THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Jefferies, Wilfred A.
  • Ribeca, Paolo

Abstract

The present invention relates to an expression vector that encodes all or a portion of replicon proteins from a positive stranded virus, wherein expression of the replicon proteins is under the control of CMV and T7 promoters, and wherein expression of a payload is under the control of a sub-genomic promoter. Also provided are methods of using the vector in therapeutics and vaccines.

IPC Classes  ?

  • C12N 15/85 - Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
  • A61K 31/713 - Double-stranded nucleic acids or oligonucleotides
  • A61K 31/7088 - Compounds having three or more nucleosides or nucleotides
  • A61K 39/12 - Viral antigens
  • A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
  • A61K 49/00 - Preparations for testing in vivo
  • A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P 31/12 - Antivirals
  • A61P 37/04 - Immunostimulants
  • C07K 14/08 - RNA viruses
  • C07K 14/18 - Togaviridae, e.g. flavivirus, pestivirus, yellow fever virus, hepatitis C virus, japanese encephalitis virus
  • C07K 14/19 - Rubella virus
  • C07K 14/165 - Coronaviridae, e.g. avian infectious bronchitis virus
  • C12N 15/40 - Proteins from RNA viruses, e.g. flaviviruses
  • C12N 15/50 - Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus
  • C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

9.

VACCINES FOR VIRAL PATHOGENS CONFERRING UNIVERSAL PROTECTION IRRESPECTIVE OF VIRAL MUTATIONS

      
Document Number 03217871
Status Pending
Filing Date 2022-05-05
Open to Public Date 2022-11-10
Owner
  • THE UNIVERSITY OF BRITISH COLUMBIA (Canada)
  • THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Ribeca, Paolo
  • Jefferies, Wilfred

Abstract

The present invention provides multi-epitope vaccines comprising or capable of expressing one or more concatemers of epitopes from a viral pathogen, namely, SARS-CoV-2. wherein at least a portion of the epitopes are from conserved viral proteins and wherein the vaccine comprises or expresses epitopes for all MHC I and MHC II alleles with a frequency > 1 % in the target population.

IPC Classes  ?

  • A61K 9/51 - Nanocapsules
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/12 - Viral antigens
  • A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
  • A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P 31/14 - Antivirals for RNA viruses
  • A61P 37/04 - Immunostimulants
  • C07K 14/005 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from viruses
  • C07K 14/165 - Coronaviridae, e.g. avian infectious bronchitis virus
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • C12N 15/50 - Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus

10.

SARS-COV-2 MULTI-EPITOPE VACCINES

      
Application Number CA2022050705
Publication Number 2022/232937
Status In Force
Filing Date 2022-05-05
Publication Date 2022-11-10
Owner
  • THE UNIVERSITY OF BRITISH COLUMBIA (Canada)
  • THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Jefferies, Wilfred
  • Ribeca, Paolo

Abstract

The present invention provides multi-epitope vaccines comprising or capable of expressing one or more concatemers of epitopes from a viral pathogen, namely, SARS-CoV-2. wherein at least a portion of the epitopes are from conserved viral proteins and wherein the vaccine comprises or expresses epitopes for all MHC I and MHC II alleles with a frequency > 1 % in the target population.

IPC Classes  ?

  • A61K 39/12 - Viral antigens
  • A61K 9/51 - Nanocapsules
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
  • A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P 31/14 - Antivirals for RNA viruses
  • A61P 37/04 - Immunostimulants
  • C07K 14/005 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from viruses
  • C07K 14/165 - Coronaviridae, e.g. avian infectious bronchitis virus
  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • C12N 15/50 - Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus

11.

A METHOD OF EPITOPE-BASED VACCINE DESIGN

      
Document Number 03199475
Status Pending
Filing Date 2021-11-23
Open to Public Date 2022-06-02
Owner
  • THE UNIVERSITY OF BRITISH COLUMBIA (Canada)
  • THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Ribeca, Paolo
  • Jefferies, Wilfred

Abstract

The present invention provides a method of epitope-based vaccine design. The method comprising: a) providing one or more target amino acid sequence(s); b) optionally discarding peptides based on one or more predetermined features; c) parsing and selecting MHC I and/or MHC II binding peptides from said sequences; and d) assembling the MHC I and/or MHC II binding peptides optionally with linkers to produce an assembly of peptides.

IPC Classes  ?

  • G16B 20/00 - ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
  • G16B 30/00 - ICT specially adapted for sequence analysis involving nucleotides or amino acids
  • G16B 35/20 - Screening of libraries
  • G16B 40/00 - ICT specially adapted for biostatisticsICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

12.

A METHOD OF EPITOPE-BASED VACCINE DESIGN

      
Application Number CA2021051666
Publication Number 2022/109726
Status In Force
Filing Date 2021-11-23
Publication Date 2022-06-02
Owner
  • THE UNIVERSITY OF BRITISH COLUMBIA (Canada)
  • THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Jefferies, Wilfred
  • Ribeca, Paolo

Abstract

The present invention provides a method of epitope-based vaccine design. The method comprising: a) providing one or more target amino acid sequence(s); b) optionally discarding peptides based on one or more predetermined features; c) parsing and selecting MHC I and/or MHC II binding peptides from said sequences; and d) assembling the MHC I and/or MHC II binding peptides optionally with linkers to produce an assembly of peptides.

IPC Classes  ?

  • G16B 40/00 - ICT specially adapted for biostatisticsICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
  • G16B 20/00 - ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
  • G16B 30/00 - ICT specially adapted for sequence analysis involving nucleotides or amino acids
  • G16B 35/20 - Screening of libraries

13.

Nanonets and spherical particles

      
Application Number 16617944
Grant Number 11548921
Status In Force
Filing Date 2018-05-31
First Publication Date 2020-06-18
Grant Date 2023-01-10
Owner The James Hutton Institute (United Kingdom)
Inventor
  • Love, Andrew John
  • Talianski, Mikhail Emmanuilovich
  • Mcgeachy, Kara

Abstract

The present invention relates to macromolecular complexes comprising micron-scale networks which include binding motifs thereon which allow the covalent bonding of the micron-scale networks to particles which provide nanoscale display surfaces. In particular the present invention relates to micron-scale networks of TMV coat proteins comprising a peptide tag (e.g. SpyTag) and particles providing a nanoscale display surface comprising GFP and a corresponding binding protein (e.g. SpyCatcher) wherein the peptide tag and binding protein pair are capable of spontaneously forming a covalent bond.

IPC Classes  ?

  • C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
  • C07K 14/005 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from viruses

14.

Glen Carron

      
Application Number 098743500
Status Pending
Filing Date 2020-03-23
Owner The James Hutton Institute (United Kingdom)
NICE Classes  ? 31 - Agricultural products; live animals

15.

COOL BEANS

      
Application Number 018070027
Status Registered
Filing Date 2019-05-20
Registration Date 2021-09-02
Owner The James Hutton Institute (United Kingdom)
NICE Classes  ?
  • 33 - Alcoholic beverages other than beer
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Alcoholic preparations for making beverages. Agriculture, aquaculture, horticulture and forestry services; agronomy [farming]; management of land [agricultural services]; management of crops; crop production; crop nutrition; crop cultivation; soil management [agricultural services]; agriculture services relating to environmental conservation; farming; information, advisory and consultancy services relating to all of the aforementioned services.

16.

Atomiser assembly

      
Application Number 15760462
Grant Number 10888891
Status In Force
Filing Date 2016-09-16
First Publication Date 2018-12-13
Grant Date 2021-01-12
Owner THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Gaskin, Graham
  • Hillier, Stephen John

Abstract

A compact apparatus for atomisation of fluid samples comprises a sonotrode (11), placed so that an ultrasonic wave emitted by the sonotrode is directed through a channel (25) in a separate channel device (21) and reflected by from the interface (26) in a high-low impedance transition zone (Tz), so that a standing wave is formed within the channel. A positive air flow through the channel, driven by a pressure differential at each end of the channel, interacts with the working fluid or slurry being delivered by a fluid delivery device (30) to atomise it. The speed of the air flow and the dispersal, homogeneity, and size of particles in the slurry sample can be controlled by varying the shape of the channel outlet.

IPC Classes  ?

  • B05B 17/06 - Apparatus for spraying or atomising liquids or other fluent materials, not covered by any other group of this subclass operating with special methods using ultrasonic vibrations
  • B06B 1/02 - Processes or apparatus for generating mechanical vibrations of infrasonic, sonic or ultrasonic frequency making use of electrical energy

17.

NANONETS AND SPHERICAL PARTICLES

      
Document Number 03067450
Status Pending
Filing Date 2018-05-31
Open to Public Date 2018-12-06
Owner THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Love, Andrew John
  • Talianski, Mikhail Emmanuilovich
  • Mcgeachy, Kara

Abstract

The present invention relates to macromolecular complexes comprising micron-scale networks which include binding motifs thereon which allow the covalent bonding of the micron-scale networks to particles which provide nanoscale display surfaces. In particular the present invention relates to micron-scale networks of TMV coat proteins comprising a peptide tag (e.g. SpyTag) and particles providing a nanoscale display surface comprising GFP and a corresponding binding protein (e.g. SpyCatcher) wherein the peptide tag and binding protein pair are capable of spontaneously forming a covalent bond.

IPC Classes  ?

  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/385 - Haptens or antigens, bound to carriers
  • C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
  • C07K 19/00 - Hybrid peptides
  • C12N 7/04 - Inactivation or attenuationProducing viral sub-units

18.

NANONETS AND SPHERICAL PARTICLES

      
Application Number GB2018051495
Publication Number 2018/220386
Status In Force
Filing Date 2018-05-31
Publication Date 2018-12-06
Owner THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Love, Andrew, John
  • Talianski, Mikhail, Emmanuilovich
  • Mcgeachy, Kara

Abstract

The present invention relates to macromolecular complexes comprising micron-scale networks which include binding motifs thereon which allow the covalent bonding of the micron-scale networks to particles which provide nanoscale display surfaces. In particular the present invention relates to micron-scale networks of TMV coat proteins comprising a peptide tag (e.g. SpyTag) and particles providing a nanoscale display surface comprising GFP and a corresponding binding protein (e.g. SpyCatcher) wherein the peptide tag and binding protein pair are capable of spontaneously forming a covalent bond.

IPC Classes  ?

  • C07K 14/315 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 39/385 - Haptens or antigens, bound to carriers
  • C07K 19/00 - Hybrid peptides
  • C12N 7/04 - Inactivation or attenuationProducing viral sub-units

19.

Glen Dee

      
Application Number 098698500
Status Pending
Filing Date 2018-03-29
Owner The James Hutton Institute (United Kingdom)
NICE Classes  ? 31 - Agricultural products; live animals

20.

ATOMISER ASSEMBLY

      
Application Number GB2016052900
Publication Number 2017/046607
Status In Force
Filing Date 2016-09-16
Publication Date 2017-03-23
Owner THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Gaskin, Graham
  • Hillier, Stephen John

Abstract

A compact apparatus for atomisation of fluid samples comprises a sonotrode (11), placed so that an ultrasonic wave emitted by the sonotrode is directed through a channel (25) in a separate channel device (21) and reflected by from the interface (26) in a high-low impedance transition zone (Tz), so that a standing wave is formed within the channel. A positive air flow through the channel, driven by a pressure differential at each end of the channel, interacts with the working fluid or slurry being delivered by a fluid delivery device (30) to atomise it. The speed of the air flow and the dispersal, homogeneity, and size of particles in the slurry sample can be controlled by varying the shape of the channel outlet.

IPC Classes  ?

  • B05B 17/00 - Apparatus for spraying or atomising liquids or other fluent materials, not covered by any other group of this subclass
  • B05B 17/06 - Apparatus for spraying or atomising liquids or other fluent materials, not covered by any other group of this subclass operating with special methods using ultrasonic vibrations

21.

Nanoparticle synthesis using plant extracts and virus

      
Application Number 14429620
Grant Number 09688964
Status In Force
Filing Date 2013-09-20
First Publication Date 2015-08-06
Grant Date 2017-06-27
Owner THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Love, Andrew John
  • Talianski, Mikhail Emmanuilovich
  • Chapman, Sean Nicholas
  • Shaw, Jane

Abstract

There is described a process for production of metal-coated virus particles or metallic nanoparticles, said process comprising admixing virus particles with plant material with reducing power and a metal salt, wherein the process can be provided in planta or ex planta and the virus particles aid the production of the metal-coated virus particles or metallic nanoparticles.

IPC Classes  ?

  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof
  • A61K 9/51 - Nanocapsules
  • B82Y 5/00 - Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

22.

ENHANCING TUBER YIELD AT ELEVATED TEMPERATURES

      
Application Number GB2014052926
Publication Number 2015/044678
Status In Force
Filing Date 2014-09-26
Publication Date 2015-04-02
Owner THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Taylor, Mark
  • Ducreux, Laurence
  • Morris, Wayne
  • Usman, Muhammad
  • Hancock, Robert

Abstract

Methods of using a homologue of TOC1a, preferably to TOC1a with a polynucleotide sequence SEQ ID NO: 1, to modulate the tuberization process in a plant and cells and plants provided by the same.

IPC Classes  ?

  • C12N 15/82 - Vectors or expression systems specially adapted for eukaryotic hosts for plant cells
  • C07K 14/415 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from plants

23.

LOCH NESS

      
Application Number 012741278
Status Registered
Filing Date 2014-03-28
Registration Date 2014-08-22
Owner The James Hutton Institute (United Kingdom)
NICE Classes  ?
  • 29 - Meat, dairy products, prepared or preserved foods
  • 31 - Agricultural products; live animals
  • 32 - Beers; non-alcoholic beverages

Goods & Services

Meat, fish, poultry, game; soups; preserved, frozen, dried, pickled, stewed and cooked fruits and vegetables; canned and bottled fruits and vegetables; candied and un-candied peels; crystallised fruits; dried fruit peel; candied fruits; fruit desserts, fruit salad; meat extracts; vegetable extracts; fruit extracts; preserves; conserves; jams; compotes; fruit spreads; fruit based spreads; vegetable spreads; fruit curds; marmalades; savoury spreads; sandwich spreads; jellies; mincemeat; pickles;  piccalilli; fruit butter; peanut butter; dairy products; dairy beverages; milk; milk products; milk beverages; yoghurt; yoghurt products; low fat yoghurt; low fat fruited yoghurt; Greek-style yoghurt; probiotic yoghurt; yoghurt beverages; beverages made from yoghurt; drinking yoghurt; flavoured yoghurt; preparations for making yogurt; yoghurt desserts; desserts comprising yogurt and fruit and/or nuts and/or cereals and/or toppings; mixtures of yoghurt and fruit preserves; crème fraîche; fromage frais; dairy desserts; desserts and puddings consisting principally of foodstuffs included in Class 29; dairy products for use in sauces, toppings and baked products; snack foods; multi-compartment meals and snacks; dips; edible oils and fats; fruit oils; blancmanges; fruit and vegetable pastes; fruit puree; fruit pulp; fruit chips; tomato puree; eggs; prepared meals and snacks; fruit based snack foods; vegetable based snack foods; fruit preserved in alcohol; desiccated coconut; raisins; butter. Grains; agricultural, horticultural and forestry products; fresh fruits and vegetables; fresh herbs; nuts; seeds; cuttings; roots; natural plants and flowers; parts of natural plants and flowers; dried plants; foodstuff for animals; malt. Non-alcoholic beverages; mineral and aerated waters; fruit drinks; fruit beverages; fruit juices; lemonade; syrups and other preparations for making beverages; non-alcoholic fruit extracts; vegetable juices; fruit nectars; sherbet beverages.

24.

NANOPARTICLE SYNTHESIS USING PLANT EXTRACTS AND VIRUS

      
Application Number GB2013052473
Publication Number 2014/045055
Status In Force
Filing Date 2013-09-20
Publication Date 2014-03-27
Owner THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Love, Andrew John
  • Talianski, Mikhail Emmanuilovich
  • Chapman, Sean Nicholas
  • Shaw, Jane

Abstract

There is described a process for production of metal-coated virus particles or metallic nanoparticles, said process comprising admixing virus particles with plant material with reducing power and a metal salt, wherein the process can be provided in planta or ex planta and the virus particles aid the production of the metal-coated virus particles or metallic nanoparticles.

IPC Classes  ?

  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof

25.

NANOPARTICLE SYNTHESIS USING PLANT EXTRACTS AND VIRUS

      
Document Number 02885658
Status In Force
Filing Date 2013-09-20
Open to Public Date 2014-03-27
Grant Date 2022-01-11
Owner THE JAMES HUTTON INSTITUTE (United Kingdom)
Inventor
  • Love, Andrew John
  • Talianski, Mikhail Emmanuilovich
  • Chapman, Sean Nicholas
  • Shaw, Jane

Abstract

There is described a process for production of metal-coated virus particles or metallic nanoparticles, said process comprising admixing virus particles with plant material with reducing power and a metal salt, wherein the process can be provided in planta or ex planta and the virus particles aid the production of the metal-coated virus particles or metallic nanoparticles.

IPC Classes  ?

  • C12N 7/00 - Viruses, e.g. bacteriophagesCompositions thereofPreparation or purification thereof

26.

Black currant plant named ‘Ben Como’

      
Application Number 13317788
Grant Number PP023416
Status In Force
Filing Date 2011-10-27
First Publication Date 2013-02-26
Grant Date 2013-02-26
Owner James Hutton Institute (United Kingdom)
Inventor Brennan, Rex M.

Abstract

Ribes nigrum, ‘Ben Como’, characterized by its consistent high yields of fruit, its upright and compact growth habit, its high degree of fruit set, its resistance to white pine blister rust and its suitability for machine harvesting, and in producing a larger plant, smaller berry, and fruit that ripens later than ‘Ben Chaska’.

IPC Classes  ?

  • A01H 5/00 - Angiosperms, i.e. flowering plants, characterised by their plant partsAngiosperms characterised otherwise than by their botanic taxonomy

27.

Black currant plant named ‘Ben Chaska’

      
Application Number 13317787
Grant Number PP023417
Status In Force
Filing Date 2011-10-27
First Publication Date 2013-02-26
Grant Date 2013-02-26
Owner James Hutton Institute (United Kingdom)
Inventor Brennan, Rex M.

Abstract

Ribes nigrum, ‘Ben Chaska’, characterized by its consistent high yields of fruit, its upright and compact growth habit, its high degree of fruit set, its resistance to white pine blister rust and its suitability for machine harvesting and in having a more compact plant habit, larger berries and earlier fruit ripening than ‘Ben Como’.

IPC Classes  ?

  • A01H 5/00 - Angiosperms, i.e. flowering plants, characterised by their plant partsAngiosperms characterised otherwise than by their botanic taxonomy

28.

SCRI

      
Application Number 005643011
Status Registered
Filing Date 2007-01-25
Registration Date 2008-02-19
Owner The James Hutton Institute (United Kingdom)
NICE Classes  ?
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Education; postgraduate training. Consultancy, research, testing, analytical, advisory, laboratory and technology transfer services; all relating to biology, molecular biology, cellular biology, biotechnology, plant pathology, bacteriology, entomology, mycology, nematology, virology, plant physiology, environmental science, agronomy, molecular ecology, vegetation dynamics, bioremediation, serology, soil physics, biomathematics, bioinformatics, statistics, chemistry, plant chemistry, biochemistry, plant biochemistry, genetics, breeding, crop science, agronomy, metabolomics, transcriptomics, plant bioactives, transgenic biology, GMO (genetically modified organism) risk assessment, diagnostics, soil biology, soil microbiology, vegetation dynamics, stable isotopes, soil-plant interactions, climate change, biodiversity, nutriceuticals, food quality, organoleptics, molecular physiology, bioengineering, environmental services and environmental protection; research, testing, analytical, laboratory and technology transfer services all relating to horticulture, agriculture, aquaculture, plant nutrition and sustainable agriculture; information, advisory and consultancy services relating to all the aforementioned services. Consultancy and advisory services all relating to horticulture, agriculture, acquaculture, plant nutrition and sustainable agriculture.

29.

Miscellaneous Design

      
Application Number 005643101
Status Registered
Filing Date 2007-01-25
Registration Date 2008-09-18
Owner The James Hutton Institute (United Kingdom)
NICE Classes  ?
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Education; postgraduate training. Consultancy, research, testing, analytical, advisory, laboratory and technology transfer services; all relating to biology, molecular biology, cellular biology, biotechnology, plant pathology, bacteriology, entomology, mycology, nematology, virology, plant physiology, environmental science, agronomy, molecular ecology, vegetation dynamics, bioremediation, serology, soil physics, biomathematics, bioinformatics, statistics, chemistry, plant chemistry, biochemistry, plant biochemistry, genetics, breeding, crop science, agronomy, metabolomics, transcriptomics, plant bioactives, transgenic biology, GMO (genetically modified organism) risk assessment, diagnostics, soil biology, soil microbiology, vegetation dynamics, stable isotopes, soil-plant interactions, climate change, biodiversity, food quality, organoleptics, molecular physiology, bioengineering, environmental services, environmental protection; research, testing, analytical, advisory, laboratory and technology transfer services , all relating to horticulture, agriculture, aquaculture, plant nutrition, sustainable agriculture, and functional food; consultancy and advisory services relating to the study, analysis and testing of, and research into, functional food; information, advisory and consultancy services relating to all the aforementioned services. Consultancy and advisory services, all relating to horticulture, agriculture, aquaculture, plant nutrition and sustainable agriculture.

30.

Glen Ample

      
Application Number 098551300
Status Pending
Filing Date 1998-06-04
Owner The James Hutton Institute (United Kingdom)
NICE Classes  ? 31 - Agricultural products; live animals